RxDoctor Payments Data

Faisal Munasifi, MD

Psychiatry · Tallahassee, FLNPI 1437222403

Payments from drug & device makers

$3,213in general payments, 2019–2025

Across 176 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$589
  • AbbVie$276
  • Alkermes, Inc.$259
  • Vanda Pharmaceuticals Inc.$259
  • Lundbeck LLC$250
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,18699%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,213 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$116,329
Medicare patients
164
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole41$65,104
Abilify MaintenaAripiprazole11$29,745
NeurontinGabapentin12$24,324
TrintellixVortioxetine Hydrobromide23$17,656
Modafinil63$4,522
Gabapentin151$2,710
Bupropion XlBupropion Hcl106$2,658
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine71$2,400
Alprazolam241$2,355
Vilazodone Hcl15$1,802
Lamotrigine160$1,800
Oxcarbazepine48$1,787
Duloxetine Hcl99$1,701
Quetiapine Fumarate107$1,472
Clonazepam180$1,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$589$94,84852 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$203$17,65623 claims
Almatica Pharma LLCSertraline Hcl$122$63672 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →